Glottic Cancer Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1064385
  • May 2021
  • Pharmaceuticals
  • 125 Pages
The Glottic Cancer Treatment Market research report comprises of an overall in depth-analysis such as market drivers, opportunities, restraints, latest developments and trends, segmentation of the market, competitive analysis, global as well as regional analysis by showcasing how each of these factors can improve the further growth of the market on an overall perspective. The report also showcases the overall market value which includes the historic data (2018-2019) and forecast data (2020-2028) generated through the revenue (USD Mn)
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Novartis, Eli Lilly And Company, Cipla Ltd., Amgen Inc., Biocon, Bristol-Myers Squibb, Engeneic Ltd, Merck & Co., Inc., Pfizer Inc., Celgene Corporation, F. Hoffmann-la Roche AG, Teva Pharmaceutical Industries Ltd
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Coverage
With the beginning of the COVID-19 pandemic in early 2020, all major economies around the world enforced severe lockdown restrictions to curb the spread of the virus. Apart from a few sectors such as healthcare and related essential services, most of the industries suffered tremendously due to inability to function in a normal fashion. Moreover, even some of the essential sectors suffered due to delays caused by supply chain disruptions and other travel complexities. However, with massive vaccination drives in most of the developed economies, some of the economies across the world experienced economic recovery from 2021. The Glottic Cancer Treatment market is expected to gain momentum in such economies and probably recover some of the losses inflicted in the year 2020. With continued efforts towards curbing the virus in the developing economies, the Glottic Cancer Treatment market is expected to attain Pre COVID-19 levels by mid-2022.

Glottic Cancer Treatment Report’s Assessment
The research report is formulated such that it offers a deep understating on the market drivers that are assimilating the growth of the market, the market opportunities that are going to provide future growth factors for the market and the market restraints which showcase the reasons as to why the market can get hampered and dissimilated. All these factors are considered keeping in view the historic and forecast analysis which can enlighten the above mentioned factors.

Thereby at a glance a reader can understand all the factors and prospects of the Glottic Cancer Treatment market and how it can assimilate and dissimilate based on each of the factors and figures mentioned in the report

Glottic Cancer Treatment Market Competitive and Premeditated Analysis
In the Glottic Cancer Treatment report major factors such latest tactical developments, competitors, research and development, participation of each region in the market and the competition among them, the latest news regarding company acquisitions and product launch, revenue of the competitors as well as the key offerings they provide all these factors are mentioned in the report with reasons to justify and understand them in depth.

The readers and purchaser of the Glottic Cancer Treatment research report can gain a comprehensive understanding of the market competition, the revenue of each major players and their contribution towards the market, attractive proposition analysis is provided in the report which sub divides the segments with respect to the largest segment that has contributed to the market growth and the fastest growing segment based on the size of the market as well as its overall appeal.
 
Major Key Players for Global Glottic Cancer Treatment Market:
The Glottic Cancer Treatment market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Novartis, Eli Lilly And Company, Cipla Ltd., Amgen Inc., Biocon, Bristol-Myers Squibb, Engeneic Ltd, Merck & Co., Inc., Pfizer Inc., Celgene Corporation, F. Hoffmann-la Roche AG, Teva Pharmaceutical Industries Ltd

The Glottic Cancer Treatment market report showcases vast potentials of growth and assimilation which is going to provide the industry numerous opportunities to grow and generate revenue by understanding the segments and which segment is a potential part to increase the disposable income in the present and upcoming years.

Glottic Cancer Treatment Market Segmentation Analysis:
Each of the segment is explained in brief along with the revenue it generates for the market based on the historic and forecast data by highlighting the largest segment and the fastest growing segment with reasons to justify it.

The Global segmentation of the Glottic Cancer Treatment market:
By Treatment Type
Non-Surgical Therapy
Surgical Therapy
Endoscopic Laser Surgery
Cordectomy
Partial Laryngectomy
End-User
Hospital Laboratories
Ambulatory Surgical Centers
Physician Office
Others

Regional Analysis of the Glottic Cancer Treatment market:
The Glottic Cancer Treatment market is dived based on different regions such as North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. And the analysis of each region is provided by highlighting the largest contribution region, the fastest growing region and the factors that is keeping the market active in the other regions is also mentioned in depth. Each regional segment also comprises of the revenue each segment holds in a specific region with reasons to justify the values.

By Regions:
  • North America (U.S and Canada)
  • Europe (U.K., Germany and France)
  • Asia Pacific (China, India and Japan)
  • Latin America (Mexico and Brazil)
  • Middle East and Africa (GCC Countries and South Africa)
 


Major Factors Included and highlighted in the Glottic Cancer Treatment report are as follows:
  • The overall market value along with historic and future data analysis.
  • The Growth drivers, opportunities and restraints are mention in detail.
  • The size of the entire Glottic Cancer Treatment market on a global perspective.
  • The CAGR value of the overall market from 2020 to 2028.
  • COVID-19 impact on the Glottic Cancer Treatment market and how it is coping up with the situation.
  • Major competitors and their contribution towards the market.
  • The segmentation analysis is included which provides a clear picture of the market bifurcation.
  • Tables and graphs that can easily been understood at a glance
  • Latest trends and news related to the Glottic Cancer Treatment market is included in the report.
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Glottic Cancer Treatment market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Glottic Cancer Treatment market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Glottic Cancer Treatment market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Glottic Cancer Treatment market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Glottic Cancer Treatment market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Novartis
  • Eli Lilly And Company
  • Cipla Ltd.
  • Amgen Inc.
  • Biocon
  • Bristol-Myers Squibb
  • Engeneic Ltd
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Celgene Corporation
  • F. Hoffmann-la Roche AG
  • Teva Pharmaceutical Industries Ltd
  • Non-Surgical Therapy
  • Surgical Therapy
  • Endoscopic Laser Surgery
  • Cordectomy
  • Partial Laryngectomy
  • Hospital Laboratories
  • Ambulatory Surgical Centers
  • Physician Office
  • Others

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Glottic Cancer Treatment Market Snapshot
          2.1.1. Global Glottic Cancer Treatment Market By Treatment Type,2019
               2.1.1.1.Non-Surgical Therapy
               2.1.1.2.Surgical Therapy
               2.1.1.3.Endoscopic Laser Surgery
               2.1.1.4.Cordectomy
               2.1.1.5.Partial Laryngectomy
          2.1.2. Global Glottic Cancer Treatment Market By End-User,2019
               2.1.2.1.Hospital Laboratories
               2.1.2.2.Ambulatory Surgical Centers
               2.1.2.3.Physician Office
               2.1.2.4.Others
          2.1.3. Global Glottic Cancer Treatment Market By End-use,2019
          2.1.4. Global Glottic Cancer Treatment Market By Geography,2019

3. Global Glottic Cancer Treatment Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Glottic Cancer Treatment Market Size (US$), By Treatment Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Treatment Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Treatment Type, 2020
     4.2. Global Glottic Cancer Treatment Market Size (US$), By Treatment Type, 2018 – 2028

5. Global Glottic Cancer Treatment Market Size (US$), By End-User, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By End-User, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By End-User, 2020
     5.2. Global Glottic Cancer Treatment Market Size (US$), By End-User, 2018 – 2028

6. Global Glottic Cancer Treatment Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Glottic Cancer Treatment Market Size (US$), By End-use, 2018 – 2028

7. Global Glottic Cancer Treatment Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Glottic Cancer Treatment Market Analysis, 2018 – 2028 
          7.2.1. North America Glottic Cancer Treatment Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Glottic Cancer Treatment Market Size (US$), By Treatment Type, 2018 – 2028
          7.2.3. North America Glottic Cancer Treatment Market Size (US$), By End-User, 2018 – 2028
          7.2.4. North America Glottic Cancer Treatment Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Glottic Cancer Treatment Market Analysis, 2018 – 2028 
          7.3.1.  Europe Glottic Cancer Treatment Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Glottic Cancer Treatment Market Size (US$), By Treatment Type, 2018 – 2028
          7.3.3. Europe Glottic Cancer Treatment Market Size (US$), By End-User, 2018 – 2028
          7.3.4. Europe Glottic Cancer Treatment Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Glottic Cancer Treatment Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Glottic Cancer Treatment Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Glottic Cancer Treatment Market Size (US$), By Treatment Type, 2018 – 2028
          7.4.3. Asia Pacific Glottic Cancer Treatment Market Size (US$), By End-User, 2018 – 2028
          7.4.4. Asia Pacific Glottic Cancer Treatment Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Glottic Cancer Treatment Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Glottic Cancer Treatment Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Glottic Cancer Treatment Market Size (US$), By Treatment Type, 2018 – 2028
          7.5.3. Latin America Glottic Cancer Treatment Market Size (US$), By End-User, 2018 – 2028
          7.5.4. Latin America Glottic Cancer Treatment Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Glottic Cancer Treatment Market Analysis, 2018 – 2028 
          7.6.1.  MEA Glottic Cancer Treatment Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Glottic Cancer Treatment Market Size (US$), By Treatment Type, 2018 – 2028
          7.6.3. MEA Glottic Cancer Treatment Market Size (US$), By End-User, 2018 – 2028
          7.6.4. MEA Glottic Cancer Treatment Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Glottic Cancer Treatment Providers
        8.4.1 Novartis
                8.4.1.1 Business Description
                8.4.1.2 Novartis Geographic Operations
                8.4.1.3 Novartis Financial Information
                8.4.1.4 Novartis Product Positions/Portfolio
                8.4.1.5 Novartis Key Developments
        8.4.2 Eli Lilly And Company
                8.4.2.1 Business Description
                8.4.2.2 Eli Lilly And Company Geographic Operations
                8.4.2.3 Eli Lilly And Company Financial Information
                8.4.2.4 Eli Lilly And Company Product Positions/Portfolio
                8.4.2.5 Eli Lilly And Company Key Developments
        8.4.3 Cipla Ltd.
                8.4.3.1 Business Description
                8.4.3.2 Cipla Ltd. Geographic Operations
                8.4.3.3 Cipla Ltd. Financial Information
                8.4.3.4 Cipla Ltd. Product Positions/Portfolio
                8.4.3.5 Cipla Ltd. Key Developments
        8.4.4 Amgen Inc.
                8.4.4.1 Business Description
                8.4.4.2 Amgen Inc. Geographic Operations
                8.4.4.3 Amgen Inc. Financial Information
                8.4.4.4 Amgen Inc. Product Positions/Portfolio
                8.4.4.5 Amgen Inc. Key Developments
        8.4.5 Biocon
                8.4.5.1 Business Description
                8.4.5.2 Biocon Geographic Operations
                8.4.5.3 Biocon Financial Information
                8.4.5.4 Biocon Product Positions/Portfolio
                8.4.5.5 Biocon Key Developments
        8.4.6 Bristol-Myers Squibb
                8.4.6.1 Business Description
                8.4.6.2 Bristol-Myers Squibb Geographic Operations
                8.4.6.3 Bristol-Myers Squibb Financial Information
                8.4.6.4 Bristol-Myers Squibb Product Positions/Portfolio
                8.4.6.5 Bristol-Myers Squibb Key Developments
        8.4.7 Engeneic Ltd
                8.4.7.1 Business Description
                8.4.7.2 Engeneic Ltd Geographic Operations
                8.4.7.3 Engeneic Ltd Financial Information
                8.4.7.4 Engeneic Ltd Product Positions/Portfolio
                8.4.7.5 Engeneic Ltd Key Developments
        8.4.8 Merck & Co., Inc.
                8.4.8.1 Business Description
                8.4.8.2 Merck & Co., Inc. Geographic Operations
                8.4.8.3 Merck & Co., Inc. Financial Information
                8.4.8.4 Merck & Co., Inc. Product Positions/Portfolio
                8.4.8.5 Merck & Co., Inc. Key Developments
        8.4.9 Pfizer Inc.
                8.4.9.1 Business Description
                8.4.9.2 Pfizer Inc. Geographic Operations
                8.4.9.3 Pfizer Inc. Financial Information
                8.4.9.4 Pfizer Inc. Product Positions/Portfolio
                8.4.9.5 Pfizer Inc. Key Developments
        8.4.10 Celgene Corporation
                8.4.10.1 Business Description
                8.4.10.2 Celgene Corporation Geographic Operations
                8.4.10.3 Celgene Corporation Financial Information
                8.4.10.4 Celgene Corporation Product Positions/Portfolio
                8.4.10.5 Celgene Corporation Key Developments
        8.4.11 F. Hoffmann-la Roche AG
                8.4.11.1 Business Description
                8.4.11.2 F. Hoffmann-la Roche AG Geographic Operations
                8.4.11.3 F. Hoffmann-la Roche AG Financial Information
                8.4.11.4 F. Hoffmann-la Roche AG Product Positions/Portfolio
                8.4.11.5 F. Hoffmann-la Roche AG Key Developments
        8.4.12 Teva Pharmaceutical Industries Ltd
                8.4.12.1 Business Description
                8.4.12.2 Teva Pharmaceutical Industries Ltd Geographic Operations
                8.4.12.3 Teva Pharmaceutical Industries Ltd Financial Information
                8.4.12.4 Teva Pharmaceutical Industries Ltd Product Positions/Portfolio
                8.4.12.5 Teva Pharmaceutical Industries Ltd Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Glottic Cancer Treatment Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Glottic Cancer Treatment Market Revenue, By Treatment Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Glottic Cancer Treatment Market Revenue, By End-User, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Glottic Cancer Treatment Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Glottic Cancer Treatment Market Revenue, By Treatment Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Glottic Cancer Treatment Market Revenue, By End-User, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Glottic Cancer Treatment Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Glottic Cancer Treatment Market Revenue, By Treatment Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Glottic Cancer Treatment Market Revenue, By End-User, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Glottic Cancer Treatment Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Glottic Cancer Treatment Market Revenue, By Treatment Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Glottic Cancer Treatment Market Revenue, By End-User, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Glottic Cancer Treatment Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Glottic Cancer Treatment Market Revenue, By Treatment Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Glottic Cancer Treatment Market Revenue, By End-User, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Glottic Cancer Treatment Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Glottic Cancer Treatment: Market Segmentation 
FIG. 2 Global Glottic Cancer Treatment Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Glottic Cancer Treatment Market, By Treatment Type, 2019 (US$ Mn) 
FIG. 5 Global Glottic Cancer Treatment Market, By End-User, 2019 (US$ Mn) 
FIG. 6 Global Glottic Cancer Treatment Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Glottic Cancer Treatment Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Glottic Cancer Treatment Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Glottic Cancer Treatment Providers, 2019
FIG. 11 Global Glottic Cancer Treatment Market Revenue Contribution, By Treatment Type, 2019 & 2028 (Value %) 
FIG. 12 Global Glottic Cancer Treatment Market Revenue Contribution, By End-User, 2019 & 2028 (Value %) 
FIG. 13 Global Glottic Cancer Treatment Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Glottic Cancer Treatment Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Glottic Cancer Treatment Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Glottic Cancer Treatment Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Glottic Cancer Treatment Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Glottic Cancer Treatment Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Glottic Cancer Treatment market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Glottic Cancer Treatment Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Glottic Cancer Treatment Market Value, By Segment1, 2018 – 2028
TABLE  North America Glottic Cancer Treatment Market Value, By Segment2, 2018 – 2028
TABLE  North America Glottic Cancer Treatment Market Value, By Country, 2018 – 2028
TABLE  Europe Glottic Cancer Treatment Market Value, By Segment1, 2018 – 2028
TABLE  Europe Glottic Cancer Treatment Market Value, By Segment2, 2018 – 2028
TABLE  Europe Glottic Cancer Treatment Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Glottic Cancer Treatment Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Glottic Cancer Treatment Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Glottic Cancer Treatment Market Value, By Country, 2018 – 2028
TABLE  Latin America Glottic Cancer Treatment Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Glottic Cancer Treatment Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Glottic Cancer Treatment Market Value, By Country, 2018 – 2028
TABLE  MEA Glottic Cancer Treatment Market Value, By Segment1, 2018 – 2028
TABLE  MEA Glottic Cancer Treatment Market Value, By Segment2, 2018 – 2028
TABLE  MEA Glottic Cancer Treatment Market Value, By Country, 2018 – 2028
TABLE  Novartis: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Eli Lilly And Company: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Cipla Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Amgen Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Biocon: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bristol-Myers Squibb: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Engeneic Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Merck & Co., Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pfizer Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Celgene Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  F. Hoffmann-la Roche AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Teva Pharmaceutical Industries Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Glottic Cancer Treatment Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Glottic Cancer Treatment Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Glottic Cancer Treatment Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Glottic Cancer Treatment Market, By Geography, 2019 (US$ Mn)
FIG.  Global Glottic Cancer Treatment Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Glottic Cancer Treatment Providers, 2016
FIG.  Global Glottic Cancer Treatment Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Surgical Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Endoscopic Laser Surgery Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Cordectomy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Partial Laryngectomy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Glottic Cancer Treatment Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Ambulatory Surgical Centers Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Physician Office Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Glottic Cancer Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Glottic Cancer Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Glottic Cancer Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Glottic Cancer Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Glottic Cancer Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Glottic Cancer Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Glottic Cancer Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Glottic Cancer Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Glottic Cancer Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Glottic Cancer Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Glottic Cancer Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Glottic Cancer Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Glottic Cancer Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Glottic Cancer Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Glottic Cancer Treatment Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Glottic Cancer Treatment Market Value, 2018 – 2028, (US$ Mn)